Shirazi, Zeinab
Adinehpour, Zohreh
Small, Toby David
Wells, R. Glenn
Boczar, Kevin E.
Chow, Benjamin J. W.
Small, Gary R.
Article History
Received: 11 January 2026
Accepted: 9 February 2026
First Online: 18 February 2026
Declarations
:
: Gary R Small reports a relationship with Alnylam Pharmaceuticals Inc that includes: speaking and lecture fees. R Glenn Wells reports a relationship with GE Healthcare that includes: funding grants. R Glenn Wells reports a relationship with Siemens that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Benjamin JW Chow reports research grants from TD Bank and AusculSciences, research support from Siemens and Artrya.
: This is an observational study The Ottawa Health Sciences Network Research Ethics Board reviewed the study protocol and has confirmed no ethical approval was required and the need for consent waived (Quality Improvement Project QI # 175).